Selective D-1 dopamine receptor agonist effects in hyperkinetic extrapyramidal disorders.
Open Access
- 1 May 1989
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 52 (5) , 631-635
- https://doi.org/10.1136/jnnp.52.5.631
Abstract
Tumours of the septum pellucidum (SP) are rare and seldom associated with memory impairment either before or after operation. A patient is described who developed amnesia after transcallosal excision of a tumour of the SP. Radiology did not show any major lesion of the brain areas traditionally associated with amnesia. Because septal nuclei could have been damaged during surgery their possible role in memory functions is discussed.This publication has 25 references indexed in Scilit:
- Selective D1and D2Receptor Manipulation in Cebus Monkeys: Relevance for Dystonia and Dyskinesia in HumansBasic & Clinical Pharmacology & Toxicology, 1987
- D 1 Dopamine Receptor Activation Required for Postsynaptic Expression of D 2 Agonist EffectsScience, 1987
- Selective D-1 dopamine receptor agonist treatment of parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1987
- Huntingtons DiseaseNew England Journal of Medicine, 1986
- Resolution and absolute configuration of an ergoline-related dopamine agonist, trans-4,4a,5,6,7,8,8a,9-octahydro-5-propyl-1H(or 2H)-pyrazolo[3,4-g]quinolineJournal of Medicinal Chemistry, 1983
- The Classification of Dopamine Receptors: Relationship to Radioligand BindingAnnual Review of Neuroscience, 1983
- Sustained bromocriptine therapy in previously untreated patients with Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1981
- Multiple receptors for dopamineNature, 1979
- Design fluency: The invention of nonsense drawings after focal cortical lesionsNeuropsychologia, 1977
- The Leyton Obsessional InventoryPsychological Medicine, 1970